• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

World Health Day Theme Is Diabetes: Prevent Type 2, Make Insulin Available

Article

The World Health Day theme highlighted the need to prevent the disease in the developing world, and the fact that many groups play a part

With brand new data showing that the global population with diabetes has reached 422 million, the World Health Organization’s selection is diabetes as its theme for World Health Day is well-timed. The day will focus on the need to prevent type 2 diabetes, especially in developing nations.

Meanwhile, in Geneva, Switzerland, a presentation of findings of the ACCISS study focused on the lack of availability of insulin for type 1 patients (and some with type 2 disease), more than 90 years after Canadian researchers discovered this life-saving therapy for patients who cannot produce their own.

According to the WHO, the aims of World Health Day are to:

· Build awareness of the global increase in the diabetes burden and its impact, especially in low- and middle-income countries.

· Create specific and affordable tactics to fight diabetes, with a focus on prevention.

· Launch a global report on diabetes, covering the impact of both type 1 and type 2 disease.

· Promote the fact that diabetes is preventable: work with food and beverage manufacturers, employers, educators, civic groups, the media and individuals themselves to change behavior.

Availability of Insulin

Researchers at the University of Geneva have been spreading the message about the cost of insulin for some time. A panel discussion today highlighted the fact that cost is barrier for about half the 100 million people who need insulin each day.

David Beran, a researcher at the University of Geneva’s division of tropical and humanitarian medicine, said there are companies that could supply cheaper insulin than the “big three”—Novo Nordisk, Sanofi, and Eli Lilly—including companies in India and China, where rates of diabetes are exploding. But discussions need to happen to create new, lower-cost sources of insulin. No generic formulations are available globally, the according to the University of Geneva group.

Related Videos
Pat Van Burkleo
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.